Skip to main content
Heidi Cuthbert CEO Grafa
Heidi Cuthbert

Heidi Cuthbert

GrafaCEO & Founder

Founder and CEO of Grafa, leading the company's vision to democratise financial data and empower investors with innovative tools.

Articles by Heidi Cuthbert

Grafa
Transport and logistics

Norwegian Cruise Line shares rise on positive Carnival outlook

Shares of Norwegian Cruise Line (NYSE:NCLH) rose by 5.9% in the morning session after its competitor, Carnival, announced strong future guidance and reinstated its dividend, fueling investor optimism across the cruise industry.

Carnival projected an adjusted net income of $3.5 billion for fiscal 2026, surpassing analysts’ expectations, and declared the return of its quarterly dividend.

Read more: Norwegian Cruise Line shares rise on positive Carnival outlook
Grafa
Health

Spero announces GSK resubmission of NDA for tebipenem HBr to treat cUTI

Spero Therapeutics (NASDAQ:SPRO) announced today that its development partner, GSK (NYSE:GSK), has resubmitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for tebipenem HBr, a treatment for complicated urinary tract infections (cUTI), including pyelonephritis.

Read more: Spero announces GSK resubmission of NDA for tebipenem HBr to treat cUTI
Grafa
Health

Psyence BioMed receives ethics approval for psilocybin trial in cancer patients

Psyence BioMed (NASDAQ:PBM) announced that it has received approval from the Bellberry Human Research Ethics Committee to use its psilocybin product, NPX5, in its ongoing Phase IIb clinical trial for adjustment disorder in cancer patients.

Read more: Psyence BioMed receives ethics approval for psilocybin trial in cancer patients